<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; or</title>
	<atom:link href="http://www.tapanray.in/tag/or/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Are common patients in India just as the pawns of the game of chess or the victims of circumstances or both, in the socio-economic milieu of the country?</title>
		<link>http://www.tapanray.in/are-common-patients-in-india-just-as-the-pawns-of-the-game-of-chess-or-the-victims-of-circumstances-or-both-in-the-socio-economic-milieu-of-the-country/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=are-common-patients-in-india-just-as-the-pawns-of-the-game-of-chess-or-the-victims-of-circumstances-or-both-in-the-socio-economic-milieu-of-the-country</link>
		<comments>http://www.tapanray.in/are-common-patients-in-india-just-as-the-pawns-of-the-game-of-chess-or-the-victims-of-circumstances-or-both-in-the-socio-economic-milieu-of-the-country/#comments</comments>
		<pubDate>Mon, 18 Jan 2010 00:30:38 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[are]]></category>
		<category><![CDATA[as]]></category>
		<category><![CDATA[both]]></category>
		<category><![CDATA[centric]]></category>
		<category><![CDATA[chess]]></category>
		<category><![CDATA[circumstances]]></category>
		<category><![CDATA[common]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[Country]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[Game]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[high]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[infrastructure]]></category>
		<category><![CDATA[just]]></category>
		<category><![CDATA[milieu]]></category>
		<category><![CDATA[MNC]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[or]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[pawns]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[price]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Socioeconomic]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[victims]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=482</guid>
		<description><![CDATA[“Public healthcare in India has the power to deliver improved health outcomes, as demonstrated by a growing number of national and international examples. However, supportive policies need to be put in place in order to change traditional determinants of health,”said &#8230; <a href="http://www.tapanray.in/are-common-patients-in-india-just-as-the-pawns-of-the-game-of-chess-or-the-victims-of-circumstances-or-both-in-the-socio-economic-milieu-of-the-country/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/are-common-patients-in-india-just-as-the-pawns-of-the-game-of-chess-or-the-victims-of-circumstances-or-both-in-the-socio-economic-milieu-of-the-country/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Collaborative commercialization of inexpensive smaller incremental innovation in Chemistry will play an important role in bringing affordable new drugs or new drug delivery systems</title>
		<link>http://www.tapanray.in/collaborative-commercialization-of-inexpensive-smaller-incremental-innovation-in-chemistry-will-play-an-important-role-in-bringing-affordable-new-drugs-or-new-drug-delivery-systems/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=collaborative-commercialization-of-inexpensive-smaller-incremental-innovation-in-chemistry-will-play-an-important-role-in-bringing-affordable-new-drugs-or-new-drug-delivery-systems</link>
		<comments>http://www.tapanray.in/collaborative-commercialization-of-inexpensive-smaller-incremental-innovation-in-chemistry-will-play-an-important-role-in-bringing-affordable-new-drugs-or-new-drug-delivery-systems/#comments</comments>
		<pubDate>Mon, 28 Dec 2009 00:30:28 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[affordable]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[bringing]]></category>
		<category><![CDATA[Chemistry]]></category>
		<category><![CDATA[Collaborative]]></category>
		<category><![CDATA[commercialization]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[important]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[incremental]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[inexpensive]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[NDDS]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[or]]></category>
		<category><![CDATA[Oxford]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[play]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[role]]></category>
		<category><![CDATA[smaller]]></category>
		<category><![CDATA[systems]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[UK]]></category>
		<category><![CDATA[Will]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=685</guid>
		<description><![CDATA[It started in the 17th century: Alchemy, a medieval chemical science and speculative philosophy aiming to achieve the transmutation of the base metals into gold, searching for a universal cure for disease and indefinitely prolonging life, not considered a science &#8230; <a href="http://www.tapanray.in/collaborative-commercialization-of-inexpensive-smaller-incremental-innovation-in-chemistry-will-play-an-important-role-in-bringing-affordable-new-drugs-or-new-drug-delivery-systems/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/collaborative-commercialization-of-inexpensive-smaller-incremental-innovation-in-chemistry-will-play-an-important-role-in-bringing-affordable-new-drugs-or-new-drug-delivery-systems/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Tackling the menace of counterfeit medicines – vested interests or petty sentiments should not make the pressing public healthcare issue irrelevant.</title>
		<link>http://www.tapanray.in/tackling-the-menace-of-counterfeit-medicines-vested-interests-or-petty-sentiments-should-not-make-the-pressing-public-healthcare-issue-irrelevant/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=tackling-the-menace-of-counterfeit-medicines-vested-interests-or-petty-sentiments-should-not-make-the-pressing-public-healthcare-issue-irrelevant</link>
		<comments>http://www.tapanray.in/tackling-the-menace-of-counterfeit-medicines-vested-interests-or-petty-sentiments-should-not-make-the-pressing-public-healthcare-issue-irrelevant/#comments</comments>
		<pubDate>Mon, 29 Jun 2009 00:30:20 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[interests]]></category>
		<category><![CDATA[irrelevant. pharmaceuticals]]></category>
		<category><![CDATA[issue]]></category>
		<category><![CDATA[Make]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[menace]]></category>
		<category><![CDATA[Not]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[or]]></category>
		<category><![CDATA[petty]]></category>
		<category><![CDATA[pressing]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[sentiments]]></category>
		<category><![CDATA[Should]]></category>
		<category><![CDATA[Tackling]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[vested]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=848</guid>
		<description><![CDATA[There are following three clearly emerging views on the global issue of counterfeit drugs:1. The innovator companies feel that the generic pharmaceutical industry and the drug regulators are not really very keen to effectively address and resolve this global public &#8230; <a href="http://www.tapanray.in/tackling-the-menace-of-counterfeit-medicines-vested-interests-or-petty-sentiments-should-not-make-the-pressing-public-healthcare-issue-irrelevant/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/tackling-the-menace-of-counterfeit-medicines-vested-interests-or-petty-sentiments-should-not-make-the-pressing-public-healthcare-issue-irrelevant/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
